Latest News from: Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Filters close
Newswise: Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Outlines Guidance for Diagnosing Pediatric and Late-Onset Multiple Sclerosis
Released: 26-Sep-2024 3:05 PM EDT
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Outlines Guidance for Diagnosing Pediatric and Late-Onset Multiple Sclerosis
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

A new review led by the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) provides guidance on how to diagnose suspected multiple sclerosis (MS) in individuals under 18 and adults 50 years and older.

Newswise: Making Connections will be the focus at the ACTRIMS Forum 2025
Released: 1-Aug-2024 12:05 PM EDT
Making Connections will be the focus at the ACTRIMS Forum 2025
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is excited to announce its tenth annual Forum, taking place from February 27 to March 1, 2025, at the Palm Beach County Convention Center and the Hilton West Palm Beach in Florida.

   
Newswise: National MS Society Awards Dr. Sergio Baranzini the Barancik Prize for Innovation in MS Research
Released: 30-Jan-2024 11:05 AM EST
National MS Society Awards Dr. Sergio Baranzini the Barancik Prize for Innovation in MS Research
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Sergio E. Baranzini, PhD, a geneticist, neuroimmunologist, and data scientist at the University of California, San Francisco, is the winner of this year’s Barancik Prize for Innovation in MS Research.

Newswise: The ninth annual ACTRIMS Forum will be held Feb. 29 - March 2 in West Palm Beach, Florida.
Released: 3-Aug-2023 11:30 AM EDT
The ninth annual ACTRIMS Forum will be held Feb. 29 - March 2 in West Palm Beach, Florida.
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Breaking Barriers in MS will be the focus at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024

19-Jul-2023 2:30 PM EDT
Is it MS or Something Else? Updated Guide is Published to Expedite and Uncover the Answer
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

An international consortium led by ACTRIMS has published detailed updated recommendations for how to distinguish suspected multiple sclerosis from other look-alike disorders. This critical guidance aims to reduce the time spent to confirm an accurate diagnosis of MS.

Newswise: ACTRIMS Forum 2023 themed MS: Going Viral
Released: 8-Sep-2022 1:05 PM EDT
ACTRIMS Forum 2023 themed MS: Going Viral
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum will be held Feb. 23-25, 2023, in San Diego, California at the Marriott Marquis San Diego Marina. Themed “MS: Going Viral,” the Forum 2023, will address the role of different viruses that have been implicated in the ongoing disease process in MS, in particular the Epstein-Barr virus, which has been associated with the onset of MS. The Forum also features the Kenneth P. Johnson Memorial Lecture, which will be delivered by Dr. Lawrence Steinman.

Newswise: ACTRIMS Board Member Dr. Amit Bar-Or Wins Barancik Prize for Innovation in MS Research
Released: 17-Feb-2022 4:05 PM EST
ACTRIMS Board Member Dr. Amit Bar-Or Wins Barancik Prize for Innovation in MS Research
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The National MS Society announced that Amit Bar-Or, MD, the Melissa and Paul Anderson President’s Distinguished Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania is this year’s recipient of the Barancik Prize for Innovation in MS Research. He is being honored for work uncovering how the immune system drives MS and for cutting-edge research focusing on precision medicine to achieve long-term remission and ultimately preventing progression of the disease.

Released: 22-Feb-2021 1:05 PM EST
Evolution of the Neuroinflammatory Response Over the Clinical Course of MS
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Benjamin M. Segal, M.D., The Ohio State University, to present keynote address at ACTRIMS Forum 2021



close
1.94479